Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study-Reference-Cited by-同舟云学术

Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study

Published:2014-09-16 Issue:5 Volume:3 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Alonso Alvaro¹,Misialek Jeffrey R.¹,Eckfeldt John H.²,Selvin Elizabeth³,Coresh Josef³,Chen Lin Y.⁴,Soliman Elsayed Z.⁵,Agarwal Sunil K.³,Lutsey Pamela L.¹

Affiliation:

1. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN

2. Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN

3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

4. Division of Cardiovascular Sciences, University of Minnesota Medical School, Minneapolis, MN

5. Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston‐Salem, NC

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. FGF-23: the rise of a novel cardiovascular risk marker in CKD

2. Fractional Excretion of Phosphorus Modifies the Association between Fibroblast Growth Factor-23 and Outcomes

3. Fibroblast Growth Factor-23 and the Long-Term Risk of Hospital-Associated AKI among Community-Dwelling Older Individuals

4. Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals

5. Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology and clinical relevance of atrial myopathy;Basic Research in Cardiology;2024-03-12

2. New Insights on Cardiac Arrhythmias in Patients With Kidney Disease;Seminars in Nephrology;2024-03

3. Fibroblast Growth Factors in Cardiovascular Disease;Journal of Atherosclerosis and Thrombosis;2024

4. Direct and indirect effects of fibroblast growth factor 23 on the heart;Frontiers in Endocrinology;2023-02-24

5. Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor kB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response;Medical Science Monitor;2022-12-20